The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study
- PMID: 31386983
- PMCID: PMC7099976
- DOI: 10.1016/j.pscychresns.2019.07.005
The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study
Abstract
One of the most statistically significant loci to result from large-scale GWAS of schizophrenia is 10q24.32. However, it is still unclear how this locus is involved in the pathoaetiology of schizophrenia. The hypothesis that presynaptic dopamine dysfunction underlies schizophrenia is one of the leading theories of the pathophysiology of the disorder. Supporting this, molecular imaging studies show evidence for elevated dopamine synthesis and release capacity. Thus, altered dopamine function could be a potential mechanism by which this genetic variant acts to increase the risk of schizophrenia. We therefore tested the hypothesis that the 10q24.32 region confers genetic risk for schizophrenia through an effect on striatal dopamine function. To this aim we investigated the in vivo relationship between a GWAS schizophrenia-associated SNP within this locus and dopamine synthesis capacity measured using [18F]-DOPA PET in healthy controls. 92 healthy volunteers underwent [18F]-DOPA PET scans to measure striatal dopamine synthesis capacity (indexed as Kicer) and were genotyped for the SNP rs7085104. We found a significant association between rs7085104 genotype and striatal Kicer. Our findings indicate that the mechanism mediating the 10q24.32 risk locus for schizophrenia could involve altered dopaminergic function. Future studies are needed to clarify the neurobiological pathway implicated in this association.
Keywords: 10q24.32; Dopamine synthesis capacity; Imaging; PET; Psychosis; Schizophrenia; Striatum.
Copyright © 2019. Published by Elsevier B.V.
Conflict of interest statement
Professor Howes has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Astra-Zeneca, Autifony, BMS, Eli Lilly, Heptares, Janssen, Lundbeck, Lyden-Delta, Otsuka, Servier, Sunovion, Rand and Roche. Neither Professor Howes nor his family have been employed by or have holdings/a financial stake in any biomedical company.
Dr D'Ambrosio reported no biomedical financial interests or potential conflicts of interest.
Dr Dahoun reported no biomedical financial interests or potential conflicts of interest.
Dr Pardiñas reported no biomedical financial interests or potential conflicts of interest.
Dr Veronese reported no biomedical financial interests or potential conflicts of interest.
Dr Bloomfield reported no biomedical financial interests or potential conflicts of interest.
Dr Jauhar reported no biomedical financial interests or potential conflicts of interest.
Dr Bonoldi reported no biomedical financial interests or potential conflicts of interest.
Dr Rogdaki reported no biomedical financial interests or potential conflicts of interest.
Dr Froudist-Walsh reported no biomedical financial interests or potential conflicts of interest.
Professor Walters reported no biomedical financial interests or potential conflicts of interest.
Figures
References
-
- (NEMA), N.E.M.A. Performance Measurements of Positron Emission Tomographs. Rosslyn, VA: NEMA; 2007. Stand. Publ. NU 2-2007.
-
- Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, Cooper TB, Mann JJ, Van Heertum RL, Gorman JM, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A. 2000;97:8104–8109. doi: 10.1073/pnas.97.14.8104. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- MR/N027078/1/MRC_/Medical Research Council/United Kingdom
- MR/L022176/1/MRC_/Medical Research Council/United Kingdom
- DH_/Department of Health/United Kingdom
- MC_U120097115/MRC_/Medical Research Council/United Kingdom
- G0700995/MRC_/Medical Research Council/United Kingdom
- MR/P005748/1/MRC_/Medical Research Council/United Kingdom
- 094849/WT_/Wellcome Trust/United Kingdom
- MR/L010305/1/MRC_/Medical Research Council/United Kingdom
- 094849/Z/10/Z/WT_/Wellcome Trust/United Kingdom
- MR/N026063/1/MRC_/Medical Research Council/United Kingdom
- MC-A656-5QD30/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
